Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-9-22
pubmed:abstractText
Secretory leukocyte protease inhibitor (SLPI) is a 12-kDa secreted protein initially identified from epithelial cells as an inhibitor of leukocyte serine proteases. In the present study, we described the identification of SLPI expression in ischemic cortex by suppression subtractive hybridization strategy. Our full-length rat SLPI cDNA shares 81% and 63% amino acid sequence identity with its mouse and human homologs, respectively, and with several polymorphisms to previous reported rat sequences. Northern blot analysis confirmed that SLPI mRNA was significantly induced in the ischemic brain tissue at 12 h (5.1-fold increase over sham controls, n = 4, p < 0.05), peaked at 2 days (26.1-fold increase, p < 0.001), and sustained up to 5 days (5.1-fold increase, p < 0.05). SLPI was localized in neurons and astrocytes in the peri-infarct zone from 24 to 72 h after middle cerebral artery occlusion by means of immunohistochemical and confocal microscopy analysis. Administration of a recombinant adenovirus overexpressing SLPI (Adv/SLPI) into the cortical tissue resulted in up to 58.4% reduction in ischemic lesion over controls at the site of Adv/SLPI expression (p < 0.01, n = 8) and significantly improved functional outcome (p < 0.01). These data suggest that the ischemia-induced expression of SLPI might play a neuroprotective role in focal stroke, possibly because of rapid inhibition of activated proteases and its suppression in inflammatory response.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0026-895X
pubmed:author
pubmed:issnType
Print
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
833-40
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:14500739-Adenoviridae, pubmed-meshheading:14500739-Amino Acid Sequence, pubmed-meshheading:14500739-Animals, pubmed-meshheading:14500739-Brain, pubmed-meshheading:14500739-Brain Ischemia, pubmed-meshheading:14500739-Cerebral Cortex, pubmed-meshheading:14500739-DNA, Complementary, pubmed-meshheading:14500739-Gene Expression, pubmed-meshheading:14500739-Gene Therapy, pubmed-meshheading:14500739-Immunohistochemistry, pubmed-meshheading:14500739-Molecular Sequence Data, pubmed-meshheading:14500739-Proteinase Inhibitory Proteins, Secretory, pubmed-meshheading:14500739-Proteins, pubmed-meshheading:14500739-RNA, Messenger, pubmed-meshheading:14500739-Rats, pubmed-meshheading:14500739-Secretory Leukocyte Peptidase Inhibitor, pubmed-meshheading:14500739-Sequence Homology, Amino Acid, pubmed-meshheading:14500739-Stroke, pubmed-meshheading:14500739-Up-Regulation
pubmed:year
2003
pubmed:articleTitle
Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury.
pubmed:affiliation
Department of Thrombosis Research, Bristol Myers Squibb Company, 311 Pennington Rocky Hill Road, Pennington, NJ 08534, USA. xinkang.wang@bms.com
pubmed:publicationType
Journal Article